0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query current partnering global congestive heart failure partnering 2010 2017.Your search for "" gave back 1533016 results.
Contrast Induced Nephropathy - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
February 2018
Price: USD 2,000.00
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Galectin 3 - Pipeline Review, H2 2019 Summary According to the recently published report 'Galectin 3 - Pipeline Review, H2 2019'; Galectin...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Congestive Heart Failure Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of %...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Medicines for Congestive Heart Failure are pharmaceutical treatments prescribed to manage the symptoms and progression of the condition. These...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Galectin 3 - Pipeline Review, H1 2020 Summary Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Contrast Induced Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Contrast Induced Nephropathy (Genitourinary Disorders) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2021
Price: USD 2,000.00
Contrast Induced Nephropathy - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
August 2020
Price: USD 2,000.00
Transmembrane Prolyl 4 Hydroxylase - Pipeline Review, H1 2020 Summary Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase...
Catalog:
Global Markets Direct
March 2020
Price: USD 3,500.00
Contrast Induced Nephropathy - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
February 2020
Price: USD 2,000.00
Contrast Induced Nephropathy - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
May 2019
Price: USD 2,000.00
